Effect of the Number of Apolipoprotein(a) Kringle 4 Domains on Immunochemical Measurements of Lipoprotein(a)

This methodological study addressed a critical measurement problem specific to lipoprotein(a): because apo(a) protein size varies enormously between individuals — due to variable numbers of tandem kringle IV type 2 repeat sequences — immunoassays that target the repeat region produce systematically biased results.

Testing antibodies against samples from 723 individuals, the investigators found that assays using antibodies against the kringle IV type 2 repeats produced isoform-dependent results — overestimating Lp(a) in people with many repeats (large isoforms) and underestimating in those with few (small isoforms). Assays using antibodies against non-repeating epitopes — apolipoprotein B or unique apo(a) domains — produced accurate, size-independent measurements across the full range of isoforms.

The practical consequence is direct. A patient with a large apo(a) isoform and genuinely elevated Lp(a) could test falsely “normal” on a repeat-region assay, and vice versa. Standardization of Lp(a) measurement requires assays calibrated against non-repeat epitopes — a technical requirement that this study laid the foundation for and that subsequent IFCC standardization work implemented.

We rate the evidence strong. Essential measurement science establishing which assay design provides reliable, size-independent Lp(a) quantification — foundational to any clinical use of Lp(a) as an actionable biomarker.